Regulatory Novo Nordisk comeback stirs as Wegovy pill wins UK approval Pharmaceutical TechnologyThere are already lengthy patient waitlists for the medication on digital health platforms.Metabolic & GLP-1Read full story pharminent June 12, 2026 (Last updated: June 12, 2026) Pharmaceutical Technology There are already lengthy patient waitlists for the medication on digital health platforms. Metabolic & GLP-1 Read full story Post navigation Previous: China’s NMPA approves Akeso’s gumokimab for plaque psoriasisNext: Novartis’ $12B Avidity buy pays dividends with Phase 1/2 muscular dystrophy win Related Stories Regulatory Bayer’s Hyrnuo set for the NSCLC frontlines on accelerated FDA label expansion pharminent September 10, 2026 Regulatory HHS appoints permanent FDA CBER, CDER heads pharminent September 10, 2026 Regulatory FDA approves AstraZeneca’s Etcamah combo for advanced breast cancer pharminent September 7, 2026